These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6159899)

  • 1. [On the galenical development of a nose spray from N-(2-imidazolin-2-yl)-N-(4-indanyl)amine monohydrochloride (indanazoline) (author's transl)].
    Dechow HJ; Lämmerhirt K; Pich CH; Schikarski M
    Arzneimittelforschung; 1980; 30(10):1738-46. PubMed ID: 6159899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline) (author's transl)].
    May HJ
    Arzneimittelforschung; 1980; 30(10):1733-7. PubMed ID: 7192113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the decongesting effect of the novel imidazole derivative N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline) (author's transl)].
    Masing H; Bengel HJ
    Arzneimittelforschung; 1980; 30(10):1785-7. PubMed ID: 6159902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic study on N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline), a new rhinologic drug].
    Neumann B; Brode E; Traut M
    Arzneimittelforschung; 1980; 30(10):1771-85. PubMed ID: 6159901
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxicity studies on N-(2-imidazolinew-2-yl)-N-(4-indanyl)amine monohydrochloride (indanazoline), a ne rhinologic drug].
    Worstmann W; Leuschner F; Neumann W; Kretzschmar R
    Arzneimittelforschung; 1980; 30(10):1760-71. PubMed ID: 6159900
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of N-(2-imidazolin-2-yl)-N-(4-indanyl)amino (indanazoline), a new vasoconstrictive imidazoline compound].
    Kretzschmar R; Lehmann HD; Gries J; Kuhne J; Neumann W
    Arzneimittelforschung; 1980; 30(10):1746-60. PubMed ID: 7192114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the absorption of decongestive nose-drops-investigation with a radioactive labelled imidazoline-derivate (author's transl)].
    Münzel M; Eichner H
    Laryngol Rhinol Otol (Stuttg); 1975 Nov; 54(11):875-88. PubMed ID: 53769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of orthogonal functions to the determination of naphazoline.
    Abdine H; Wahbi AM; Korany MA
    J Pharm Pharmacol; 1972 Jul; 24(7):522-4. PubMed ID: 4116401
    [No Abstract]   [Full Text] [Related]  

  • 9. [Which nasal spray is preferred by patients?].
    Månsson I; Fredriksson H
    Lakartidningen; 1991 Feb; 88(6):406. PubMed ID: 1705641
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improving wound healing after nose surgery by combined administration of xylometazoline and dexpanthenol].
    Kehrl W; Sonnemann U
    Laryngorhinootologie; 2000 Mar; 79(3):151-4. PubMed ID: 10763172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The galenic development of a tablet with ameziniummetilsulfate.
    Moest T; Dechow HJ; Pich CH
    Arzneimittelforschung; 1981; 31(9a):1623-38. PubMed ID: 7197977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
    Müller F
    Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotton pledget packing versus topical spray for nasal preparation: merits and demerits are answered by a strict randomized controlled trial.
    Hu CT
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1763-4. PubMed ID: 23233314
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study of L 5818 Labaz used as a vasocontrictor in nasal instillation].
    Melon J; Boniver R; Zicot-Houters L
    Acta Otorhinolaryngol Belg; 1974; 28(3):355-64. PubMed ID: 4138436
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with Rhinogutt nose drops].
    Czermak L
    Dtsch Med J; 1969 Mar; 20(5):154-5. PubMed ID: 4182484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of naphazoline and naphthylacetylethylenediamine in a mixture with sodium tetraphenylboron].
    Gracia H; Bonnard J
    Farmaco Prat; 1972 Jan; 27(1):39-48. PubMed ID: 4110443
    [No Abstract]   [Full Text] [Related]  

  • 17. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
    Jessen M; Ivarsson A; Malm L
    Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative preference study between xylometazoline nasal dose spray (Otrivin) and oxymetazoline single-dose pipettes (Nezeril).
    Ekedahl C; Geterud A; Petruson B; Aust R; Odkvist L
    Rhinology; 1983 Sep; 21(3):287-8. PubMed ID: 6195722
    [No Abstract]   [Full Text] [Related]  

  • 19. [The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters].
    Verse T; Sikora C; Rudolph P; Klöcker N
    Laryngorhinootologie; 2003 Nov; 82(11):782-9. PubMed ID: 14634896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trials of Otrivin nose drops--experiences with infants and young children].
    Mizukoshi O; Imamura T; Sasaki H; Kawamoto S
    Jibiinkoka; 1969 Mar; 41(3):213-5. PubMed ID: 4181775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.